VTRSライブシグナル | Getagraph.comで利益を最大化

売る 46 min ago

@ $11.76

発行日: 30 4月 2024 @ 00:57

リターン: 0.13%

前回のシグナル: 4月 27 - 04:44

前回のシグナル: 買う

リターン: 1.38 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:44):

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets...

Stats
本日の出来高	1.36M
平均出来高	8.81M
時価総額	13.98B
EPS	$0 ( 2024-02-28 )
次の収益日	( $0 ) 2024-05-06
Last Dividend	$0.120 ( 2023-11-22 )
Next Dividend	$0 ( N/A )
P/E	235.50
ATR14	$0.289 (2.45%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Le Goff Corinne	Buy	110 162	Restricted Stock Units
2024-04-18	Le Goff Corinne	Buy	78 688	Restricted Stock Units
2024-04-15	Le Goff Corinne	Buy	0
2024-04-02	Malik Rajiv	Buy	18 845	Restricted Stock Units
2024-03-13	Mauro Anthony	Sell	250 000	Common Stock

INSIDER POWER
9.39
Last 99 transactions
Buy: 1 339 847 \| Sell: 1 117 278

ボリューム相関

長: 0.88 (strong)

短: 0.34 (neutral)

Signal:(51) Neutral

Viatris Inc. 相関

10 最も正の相関
MMAC	0.897
NETE	0.888
SRAC	0.833
AMRB	0.83
RAVN	0.829
BRKH	0.824
DOOO	0.824
EUSG	0.819
BOCH	0.817
TKNO	0.816

10 最も負の相関
SVOK	-0.94
PAIC	-0.907
SVAC	-0.9
RMRM	-0.883
FEYE	-0.846
TLGT	-0.841
SPRT	-0.83
FTOCU	-0.823
FTOC	-0.815
OPCH	-0.808

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Viatris Inc. 相関 - 通貨/商品

-0.12
( neutral )

0.58
( weak )

0.00
( neutral )

0.12
( neutral )

-0.76
( moderate negative )

0.13
( neutral )

Viatris Inc. 財務諸表

Annual	2023
収益:	$15.38B
総利益:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2023
収益:	$15.38B
総利益:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2022
収益:	$16.26B
総利益:	$6.50B (39.95 %)
EPS:	$1.710

FY	2021
収益:	$17.89B
総利益:	$5.58B (31.17 %)
EPS:	$-2.11

Financial Reports:

No articles found.

Viatris Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.240 (N/A)	$0.120 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Viatris Inc. Dividend Information - Dividend King

Dividend Sustainability Score: 6.81 - average (93.69%) | Divividend Growth Potential Score: 4.62 - Stable (7.56%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00741	1986-12-24
Last Dividend	$0.120	2023-11-22
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	88	--
Total Paid Out	$2.99	--
Avg. Dividend % Per Year	2.32%	--
Score	5.02	--
Div. Sustainability Score	6.81
Div.Growth Potential Score	4.62
Div. Directional Score	5.72	--

Next Divdend (Est)
(2024-06-03)

$0.123 Estimate 35.64 %

Dividend Stability

0.71 Good

Dividend Score

5.02

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1986	$0.00741	0.28%
1987	$0.0148	0.88%
1988	$0.0111	0.86%
1989	$0.0148	1.13%
1990	$0.0222	0.63%
1991	$0.0296	1.01%
1992	$0.0326	0.53%
1993	$0.0416	0.46%
1994	$0.0564	0.78%
1995	$0.0652	0.85%
1996	$0.0712	0.70%
1997	$0.0712	0.97%
1998	$0.0712	0.80%
1999	$0.0712	0.53%
2000	$0.0712	0.66%
2001	$0.0712	0.65%
2002	$0.0756	0.47%
2003	$0.0966	0.61%
2004	$0.120	0.48%
2005	$0.210	1.20%
2006	$0.240	1.20%
2007	$0.120	0.60%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0.330	1.78%
2022	$0.480	3.38%
2023	$0.600	5.27%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00355	1.500	9.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00115	1.200	9.96	10.00	[0 - 0.3]
returnOnEquityTTM	0.00263	1.500	-1.082	-1.623	[0.1 - 1]
payoutRatioTTM	10.52	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.572	0.800	7.14	5.71	[1 - 3]
quickRatioTTM	0.658	0.800	-0.833	-0.666	[0.8 - 2.5]
cashRatioTTM	0.128	1.500	-0.401	-0.602	[0.2 - 2]
debtRatioTTM	0.382	-1.500	3.63	-5.45	[0 - 0.6]
interestCoverageTTM	1.886	1.000	-0.413	-0.413	[3 - 30]
operatingCashFlowPerShareTTM	2.33	2.00	9.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.937	2.00	9.03	10.00	[0 - 20]
debtEquityRatioTTM	0.890	-1.500	6.44	-9.66	[0 - 2.5]
grossProfitMarginTTM	0.419	1.000	6.36	6.36	[0.2 - 0.8]
operatingProfitMarginTTM	0.0708	1.000	-0.585	-0.585	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.154	1.000	-0.257	-0.257	[0.2 - 2]
assetTurnoverTTM	0.323	0.800	-1.178	-0.943	[0.5 - 2]
Total Score				6.81

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	253.84	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00263	2.50	-0.695	-1.623	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.937	2.00	9.35	10.00	[0 - 30]
dividendYielPercentageTTM	4.15	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.33	2.00	9.22	10.00	[0 - 30]
payoutRatioTTM	10.52	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-1.592	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.182	1.000	7.96	0	[0.1 - 0.5]
Total Score				4.62

Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.